Kobayashi Pharmaceutical Co., Ltd. (FRA:KOY)

Germany flag Germany · Delayed Price · Currency is EUR
30.20
+0.40 (1.34%)
At close: Sep 26, 2025
1.34%
Market Cap2.30B
Revenue (ttm)953.05M
Net Income (ttm)69.63M
Shares Outn/a
EPS (ttm)0.94
PE Ratio33.01
Forward PEn/a
Dividend0.62 (2.05%)
Ex-Dividend DateJun 27, 2025
Volume25
Average Volumen/a
Open30.20
Previous Close29.80
Day's Range30.20 - 30.20
52-Week Range28.80 - 39.20
Betan/a
RSI43.00
Earnings DateNov 11, 2025

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese medicine; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air freshener, lens cleaner, coolin... [Read more]

Industry Pharmaceutical Preparations
Founded 1886
Employees 3,615
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol KOY
Full Company Profile

Financial Performance

In 2024, Kobayashi Pharmaceutical's revenue was 165.60 billion, a decrease of -4.53% compared to the previous year's 173.46 billion. Earnings were 10.07 billion, a decrease of -50.50%.

Financial numbers in JPY Financial Statements

News

There is no news available yet.